We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LPCN market cap is 37.21M. The company's latest EPS is USD -3.0761 and P/E is -2.31.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 55k | 0 | 0 | -2.91M |
| Operating Income | -2.56M | -4.34M | -3.96M | -7.04M | -2.59M |
| Net Income | -2.23M | -3.87M | -3.55M | -6.65M | -2.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 165k | 0 | 16.14M | 500k | -2.85M |
| Operating Income | -12.9M | -18M | 3.15M | -12.12M | -17.93M |
| Net Income | -13.01M | -20.97M | -634k | -10.76M | -16.35M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.54M | 34.02M | 30.48M | 24.75M | 23M |
| Total Liabilities | 1.91M | 2.06M | 1.93M | 2.27M | 2.63M |
| Total Equity | 35.64M | 31.96M | 28.55M | 22.48M | 20.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.66M | 25.35M | 52.48M | 37.54M | 23M |
| Total Liabilities | 13.37M | 10.01M | 6.91M | 1.91M | 2.63M |
| Total Equity | 6.29M | 15.34M | 45.57M | 35.64M | 20.37M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.97M | -3.93M | -7.24M | -9.84M | -11.87M |
| Investing | 14.29M | 5.56M | 9.12M | 10.36M | 13.09M |
| Financing | -2.13M | -6k | -11k | 410k | 405k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.67M | -15.3M | -4.41M | -11.97M | -11.87M |
| Investing | 3M | 3.89M | -43.78M | 14.29M | 13.09M |
| Financing | 10.32M | 20.9M | 26.93M | -2.13M | 405k |
| Market Cap | 37.21M |
| Price to Earnings Ratio | -2.31 |
| Price to Sales Ratio | -13.24 |
| Price to Cash Ratio | 7.91 |
| Price to Book Ratio | 1.85 |
| Dividend Yield | - |
| Shares Outstanding | 5.32M |
| Average Volume (1 week) | 24.48k |
| Average Volume (1 Month) | 27.93k |
| 52 Week Change | 55.56% |
| 52 Week High | 7.15 |
| 52 Week Low | 2.3101 |
| Spread (Intraday) | 0.11 (1.57%) |
| Company Name | Lipocine Inc |
| Address |
919 north market street wilmington, delaware 19801 |
| Website | https://www.lipocine.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
